Stefanie Aeppli

6PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|Jun 10, 2025
A Bayesian Network Meta-analysis of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer in First- and Subsequent Lines.

Marie Wosny, Stefanie Aeppli, Stefanie Fischer

|Feb 25, 2025
First Single-Centre Experience with the Novel HIF-α Inhibitor Belzutifan in Switzerland.

Tobias Peres, Stefanie Aeppli, Stefanie Fischer

|Aug 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.

Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz

|Dec 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

A A Moccia, S Aeppli, S Güsewell

|Aug 04, 2018
Systemic treatment of a patient with relapsed and refractory extranodal NK/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab.

Stefanie Aeppli, Christoph Driessen, Lukas Graf

Pageof 1

Frequent Collaborators

2 joint publications

Richard Cathomas

2 joint publications

Sacha I Rothschild

2 joint publications

Stefanie Hayoz

2 joint publications

Lukas Bubendorf